University of Colorado, Boulder
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Colorado, Boulder sits in the top decile of US sponsors by registered trial count (#307 of 15,742 sponsors by registered trial count).
University of Colorado, Boulder: 69 sponsored US clinical trials, 15 recruiting.
University of Colorado, Boulder sponsors 69 registered US clinical trials on ClinicalTrials.gov, 15 of them currently recruiting, and 48 completed. 3 of these trials are in Phase 3-4 (later-stage) and 9 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Aging, with 4 trials.
Top-decile sponsor footprint
University of Colorado, Boulder ranks in the top decile of sponsors by registered trial count (#307 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
48 of 49 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (98.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
69 total, page 2 of 2
Perinatal Emotion and Relationships Longitudinal Study
NCT03027037
The Microbiome and Resilience to Sleep and Circadian Disruption
NCT03747367
The Efficacy of Oral Mitoquinone (MitoQ) Supplementation for Improving Physiological in Middle-aged and Older Adults
NCT02597023
Acceptance and Commitment Therapy (ACT) for Anxious Cancer Survivors
NCT02550925
Safety & Efficacy of Nicotinamide Riboside Supplementation for Improving Physiological Function in Middle-Aged and Older Adults
NCT02921659
Nitrite Supplementation for Improving Physiological Function in Older Adults
NCT02393742
Exercise and Markers of Medial Temporal Health in Youth At-risk for Psychosis
NCT02155699
Neuromuscular Electrical Stimulation and Mobility in Multiple Sclerosis
NCT02152085
Enhancing Function in Later Life: Exercise and Functional Network Connectivity
NCT02068612
DNA Methylation and Cancer Prevention: Duration and Intensity of Exercise
NCT02032628
Oral Trehalose Therapy to Reverse Arterial Aging in Middle-Aged and Older Adults
NCT01575288
Nebivolol and Endothelial Regulation of Fibrinolysis (NERF)
NCT01595516
Sodium Nitrite to Treat Arterial Aging
NCT02022670
Nebivolol and the Endothelin (ET)-1 System
NCT01395329
Mindfulness-Based Cognitive Therapy for the Prevention of Perinatal Depressive Relapse/Recurrence
NCT02387424
Efficacy of Dietary Sodium Restriction of Improving Vascular Endothelial Function in Middle Aged and Older Adults
NCT01566084
The Staying Well Study: An Open Trial of Mindfulness-Based Cognitive Therapy for the Prevention of Perinatal Depression
NCT02391870
A Dose Response Effect of Atomoxetine to the Acute Effects of Alcohol
NCT01408589
Efficacy of Voice Treatment for Parkinson's Disease
NCT00123084
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 4 |
| Phase 4 | 3 |
Therapeutic Areas
What is open in the University of Colorado, Boulder pipeline
15 recruiting of 69 indexed (22% open); 48 completed (70%).
Phase mix: 3 late (III/IV) vs 9 early (I/II) (early-phase heavy).
Top condition: Aging (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Colorado, Boulder: open-pipeline peers nationwide
Peers matched on 69 registered trials and 22% open enrollment, not the therapeutic-area sidebar.
University of Colorado, Boulder sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 69 trials (± recruiting share)
- Mallinckrodt · 69 trials · 0% recruiting
- Providence Health & Services · 69 trials · 7% recruiting
- Texas Tech University · 69 trials · 17% recruiting
- Procter and Gamble · 70 trials · 0% recruiting
Sponsors near 22% open enrollment (± trial volume)
- AtriCure · 22% recruiting · 23 trials
- University of Maryland, College Park · 22% recruiting · 46 trials
- Regeneron Pharmaceuticals · 22% recruiting · 280 trials
- Henry M. Jackson Foundation for the Advancement of Military Medicine · 22% recruiting · 60 trials
Related
What to do with this University of Colorado, Boulder page
69 registered trials is a research-attention snapshot, not an endorsement of University of Colorado, Boulder or any single study.
- 15 of University of Colorado, Boulder's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Aging is the condition University of Colorado, Boulder studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Aging trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Colorado, Boulder pipeline card: 69 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.